Harris NL (1992) Ferry JA (1992) follicular lymphoma and related disorders (germinal center lymphomas). In: Knowles DM (ed) Neoplastic Hematopathology. Williams &Wilkins, Baltimore, p 645
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, Wolf-Peeters CD, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84:1361–1392
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390
Jaffe ES, Raffeld M, Mederios LJ (1993) Histopathologic subtypes of indolent lymphomas: caricatures of the mature B-cell system. Semin Oncol 20(suppl 5):3
Martin AR, Weisenburger DD, Chan WC, Ruby EI, Anderson JR, Vose JM, Bierman PJ, Bast MA, Daley DT, Armitage JO (1995) Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood 85:3671–3678
Oviatt DL, Vousar JB, Collins RD, Flexner JM, Stein RS (1984) Malignant lymphomas of follicular center cell origin in humans. V. Incidence, clinical features, and prognostic implications of transformation of small cleaved cell nodular lymphoma. Cancer 53:1109
Shustik J, Quinn M, Connors JM, Gascoyne RD, Skinnider B, Sehn L (2008) Follicular non-Hodgkin lymphoma grade 3a and 3b subtypes exhibit similar clinical behaviour and treatment outcome. Blood 112(11):3777
ErsbØll J, Schultz HB, Perdersen-Bjergaard J, Nissen NJ (1989) Follicular low-grade non-Hodgkin lymphomas: long-term outcome with or without tumor progression. Eur J Haematol 42:155
Sundaram S, Moore E, Ayyappan S, Covut F, Tomlinson B, Creger R, Malek E, Metheny L, Cooper BW, Lazarus HM, Lima M, Caimi P (2017) Effect of histologic grade on clinical outcomes of follicular lymphoma: prolonged progression free survival of grade 3 follicular lymphoma in the rituximab era. Blood 130(Supplement 1):2775
Salmon SE, Seligmann M (1974) B-cell neoplasia in man. Lancet.;2(7891):1230–1233. https://doi.org/10.1016/s0140-6736(74)90748-x
Seifert M, Scholtysik R, Küppers R (2019) Origin and pathogenesis of B cell lymphomas. Methods Mol Biol 1956:1–33. https://doi.org/10.1007/978-1-4939-9151-8_1
Article CAS PubMed Google Scholar
Kluin PM (2013) Origin and migration of follicular lymphoma cells. Haematologica. 98(9):1331–1333. https://doi.org/10.3324/haematol.2013.091546
Article CAS PubMed PubMed Central Google Scholar
Carbone A, Roulland S, Gloghini A, Younes A, von Keudell G, López-Guillermo A, Fitzgibbon J (2019) Follicular lymphoma. Nat Rev Dis Primers 5:83. https://doi.org/10.1038/s41572-019-0132-x
Zelenetz AD, Chen TT, Levy R (1992) Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection. J Exp Med 176:1137–1148
Bahler DW, Levy R (1992) Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc Natl Acad Sci U S A 89:6770–6774
Deane M, Norton JD (1990) Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias. Eur J Immunol 20:2209–2217
Sanz I, Kelly P, Williams C, Scholl S, Tucker P, Capra JD (1989) The smaller human VH gene families display remarkably little polymorphism. EMBO J 8:3741–3748
Tomlinson IM, Walter G, Marks JD, Llewelyn MB, Winter G (1992) The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol 227:776–798
Chen PP (1990) Structural analyses of human developmentally regulated VH3 genes. Scand J Immunol 31:257–267
Baer R, Forster A, Lavenir I, Rabbitts TH (1988) Immunoglobulin VH genes are transcribed by T cells in association with a new 5′ exon. J Exp Med 167:2011–2016
Chang B, Casali P (1994) The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today 15:367–373
Okosun J, Bödör C, Wang J, Araf S, Yang CY, Pan C, Boller S, Cittaro D, Bozek M, Iqbal S, Matthews J, Wrench D, Marzec J, Tawana K, Popov N, O'Riain C, O'Shea D, Carlotti E, Davies A, Lawrie CH, Matolcsy A, Calaminici M, Norton A, Byers RJ, Mein C, Stupka E, Lister TA, Lenz G, Montoto S, Gribben JG, Fan Y, Grosschedl R, Chelala C, Fitzgibbon J (2014) Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat Genet 46:176–181
Green MR, Kihira S, Liu CL (2015) Et al. (2015) mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. Proc Natl Acad Sci 112:1116–1125
Lackraj T, Goswami R, Kridel R (2018) (2018) pathogenesis of follicular lymphoma. Best Pract Res Clin Haematol 31:2–14
Randall C, Fedoriw Y (2020) Pathology and diagnosis of follicular lymphoma and related entities. Pathology 52(1):30–39. https://doi.org/10.1016/j.pathol.2019.09.010
Article CAS PubMed Google Scholar
Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB, Ouillette P, Trifonov V, Rossi D, Tabbò F, Ponzoni M, Chadburn A, Murty VV, Bhagat G, Gaidano G, Inghirami G, Malek SN, Rabadan R, Dalla-Favera R (2014) (2014) genetics of follicular lymphoma transformation. Cell Rep 6:130–140
Bouska A, Zhang W, Gong Q, Iqbal J, Scuto A, Vose J, Ludvigsen M, Fu K, Weisenburger DD, Greiner TC, Gascoyne RD, Rosenwald A, Ott G, Campo E, Rimsza LM, Delabie J, Jaffe ES, Braziel RM, Connors JM, Wu CI, Staudt LM, D‘Amore F, McKeithan TW, Chan WC (2017) Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma. Leukemia. 31:83–91
Wartenberg M, Vasil P, Meyer zum Bueschenfelde C, Ott G, Rosenwald A, Fend F, Kremer M (2013) Somatic Hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse. Haematologica 98(9):1433–1441. https://doi.org/10.3324/haematol.2012.074252
Article PubMed PubMed Central Google Scholar
Bognár A, Csernus B, Bödör C, Reiniger L, Szepesi A, Tóth E, Kopper L, Matolcsy A (2005) Clonal selection in the bone marrow involvement of follicular lymphoma. Leukemia. 19(9):1656–1662. https://doi.org/10.1038/sj.leu.2403844
Schroeder HW, Dighiero G (1994) The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 15:288–294
Dunn-Walters D, Thiede C, Alpen B, Spencer J (2001) Somatic hypermutation and B-cell lymphoma. Philos Trans R Soc Lond B Biol Sci 356(1405):73–82. https://doi.org/10.1098/rstb.2000.0751
Article CAS PubMed PubMed Central Google Scholar
Zuckerman NS, McCann KJ, Ottensmeier CH, Barak M, Shahaf G, Edelman H, Dunn-Walters D, Abraham RS, Stevenson FK, Mehr R (2010) Ig gene diversification and selection in follicular lymphoma, diffuse large B cell lymphoma and primary central nervous system lymphoma revealed by lineage tree and mutation analyses. Int Immunol 22(11):875–887. https://doi.org/10.1093/intimm/dxq44
Article CAS PubMed Google Scholar
Küppers R, Schneider M, Hansmann ML (2019) Laser-based microdissection of single cells from tissue sections and PCR analysis of rearranged immunoglobulin genes from isolated normal and malignant human B cells. In: Küppers R (ed) Lymphoma. Methods in molecular biology, 1956. Humana Press, New York
Kridel R, Chan FC, Mottok A et al (2016) Histological transformation and progression in follicular lymphoma: a clonal evolution study. PLoS Med 13:e1002197. https://doi.org/10.1371/journal.pmed.1002197
Article CAS PubMed PubMed Central Google Scholar
Horn H, Kohler C, Witzig R, Kreuz M, Leich E, Klapper W, Hummel M, Loeffler M, Trümper L, Spang R, Rosenwald A, Ott G, for the Molecular Mechanisms in Malignant Lymphomas (MMML) Network Proje
Comments (0)